Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ABT
ABT logo

ABT News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

ABT News

Surging Demand for GLP-1 Drugs Benefits Medical Device Companies

6h agoFool

Dividend Kings: Steady Growth Investment Choices

9h agoFool

Long-Term Investment Strategy in Healthcare Sector

1d agoFool

Omnipod 5 Insulin Delivery System Launches in Spain

1d agoYahoo Finance

AbbVie Q1 Earnings Beat Expectations, Market Reacts Positively

4d agoYahoo Finance

Schwab U.S. Dividend ETF Shows Strong Performance

4d agoNASDAQ.COM

The Potential and Returns of Dividend Investing

4d agoFool

Investment Comparison: Abbott vs. Intuitive Surgical

6d agoFool

ABT Events

07/01 09:00
Tandem Diabetes Care Launches Insulin Pump Compatible with Abbott Sensor
Tandem Diabetes Care (TNDM) announced that the t:slim X2 insulin pump with Control-IQ+ automated insulin delivery, AID, technology is now compatible with Abbott's (ABT) FreeStyle Libre 3 Plus continuous glucose monitoring, CGM, sensor in five countries. This launch expands continuous glucose monitoring choice for t:slim X2 pump users in the United Kingdom, Switzerland, Sweden, Finland, and Italy. Tandem expects to add additional countries in 2026, including Belgium, the Netherlands, and Germany. "People using AID want flexibility in the devices they use," said Jordan Pinsker, MD, chief medical officer. "The addition of Abbott's latest generation sensor expands CGM choice for people using our Control-IQ+ technology."

ABT Monitor News

Baird Upgrades Abbott Laboratories to Outperform with $121 Target

Jul 02 2026

Abbott Partners with ALZpath for Alzheimer's Diagnostic Innovation

Jun 25 2026

Abbott Laboratories shows strong growth potential amid market challenges

Jun 04 2026

Abbott Laboratories Faces Challenges Amid Legal Pressure and Market Conditions

May 08 2026

Abbott Reports Q1 2026 Growth Amid Acquisition Impact

Apr 21 2026

Abbott Reports Strong Q1 2026 Financial Results with Strategic Acquisition

Apr 16 2026

Abbott Ordered to Pay $53M for Infant Formula Lawsuit

Apr 10 2026

Abbott Reports Q4 2025 Earnings with Mixed Results

Jan 22 2026

ABT Earnings Analysis

Abbott Q1 2024 Earnings: Strong Results Despite Challenges- Intellectia AI™
1 years ago
Abbott Q1 2025: Strong Growth in Medical Devices- Intellectia AI™
1 years ago
Abbott's Resilient Growth in Healthcare - Intellectia AI™
1 years ago

People Also Watch